These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Overview of the randomized phase III trials in non-small cell lung cancer in North America. Kelly K Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-2-S8-5. PubMed ID: 9207308 [TBL] [Abstract][Full Text] [Related]
8. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer. Socinski MA; Shea TC Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121 [TBL] [Abstract][Full Text] [Related]
10. Triplet chemotherapy combinations with new agents: is there a rationale? Bunn PA Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586 [TBL] [Abstract][Full Text] [Related]
11. Multimodality therapy in the treatment of lung cancer. Rivera MP Semin Respir Crit Care Med; 2004; 25 Suppl 1():3-10. PubMed ID: 16088515 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective. Sasidharan R; Gibbs D; Sullivan R; Simpson A; Perez D; Christmas T; McKeage M N Z Med J; 2006 Nov; 119(1245):U2310. PubMed ID: 17146485 [TBL] [Abstract][Full Text] [Related]
13. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
14. Combined modality therapy for non-small cell lung carcinoma. Machtay M; Glatstein E Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703 [TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)]. Eberhardt W Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686 [TBL] [Abstract][Full Text] [Related]
17. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions. Bunn PA Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ; J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657 [TBL] [Abstract][Full Text] [Related]
19. Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer. Palmer M; Parker J; Modi S; Butts C; Smylie M; Meikle A; Kehoe M; MacLean G; Longenecker M Clin Lung Cancer; 2001 Aug; 3(1):49-57; discussion 58. PubMed ID: 14656392 [TBL] [Abstract][Full Text] [Related]
20. L-BLP25 as a peptide vaccine therapy in non-small cell lung cancer: a review. Xia W; Wang J; Xu Y; Jiang F; Xu L J Thorac Dis; 2014 Oct; 6(10):1513-20. PubMed ID: 25364531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]